Your prospects speak in assay data and MOAs. So does your outbound.

Two things. First, we only work with life sciences companies — we don't do fintech on Mondays and biotech on Tuesdays. Second, our founder writes a daily biotech newsletter read by 2,200+ professionals. That means we're immersed in your buyers' world every single day, not learning it from a brief. When we write outreach, it references real industry developments your prospects recognize.

Setup takes about two weeks. Campaigns go live in week three. Most clients see their first qualified meetings within 30 days of campaign launch. Pipeline compounds from there as we optimize messaging and expand targeting.

Every message references your real product capabilities and publicly available documentation. We use AI-driven personalization systems that we've trained on life sciences contexts — not generic templates with a company name swapped in. The result reads like it was written by someone who's been to AAPS and actually paid attention.

Good — that's where we do our best work. Whether you're targeting vaccine fill-finish decision-makers or heads of analytical development at pre-commercial biotechs, we've built targeting for similarly specific audiences. If we genuinely don't think we can help, we'll tell you on the first call.

We hand over everything — processes, playbooks, SOPs, tool configurations, and templates. It's your infrastructure. We can also stay on as consultants during the transition to make sure nothing drops.

Pricing depends on scope — which channels you want active, the scale of targeting, and whether you're adding the LinkedIn authority building program. We'll build a proposal on our strategy call that's tailored to your goals. No surprises, no hidden fees.